Filling in small medicine bottles

Ireland has established itself as a premier global hub for pharmaceutical manufacturing and clinical research, hosting many of the world’s top life science companies.

The rapid evolution of the industry has fundamentally changed supply chain requirements, accelerated by the rise in DTP clinical trials and demand for advanced therapeutics.​

Explore Ireland’s pivotal position in the global pharma landscape, QuickSTAT’s commitment, and the logistics infrastructure designed to support the market’s expanding needs.​

What you'll learn

  • Discover the key factors that have positioned Ireland as a leading global cluster for pharmaceutical and biopharmaceutical innovation.

  • Understand how the rise of decentralised and DTP clinical trials is shifting paradigms and impacting traditional supply chains.​

  • Learn about the rigorous temperature-control and handling capabilities required to move high-value biopharma products safely in and out of the region.

  • Explore how QuickSTAT is expanding its local presence, resources, and operational expertise to seamlessly align with Ireland's growing pharma sector.

Loading iFrame

Press play to get started.

Why it matters

  • As a major exporter of life-saving medicines, Ireland's logistics infrastructure directly impacts global drug availability and clinical trial timelines.

  • The transition to DTP and decentralised trials requires highly specialized and agile courier networks that ensure patient compliance and safety.​

  • Biopharmaceutical products manufactured in Ireland often require strict temperature management; robust logistics prevent costly product loss and preserve efficacy.

  • Aligning with a dedicated logistics partner ensures that Irish pharma hubs remain resilient against evolving global regulatory and distribution challenges.